Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation Stollery Children’s Hospital
Country Canada
Scopus ID 57219721692
Documents 9
Citations 478
h-index 7
Subject Area Congenital Heart Defects
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

References

  1. Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
    https://www.scopus.com/pages/authors/57219721692
  2. ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
    https://orcid.org/0000-0003-0094-0193
  3. Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
    https://doi.org/10.1186/s12968-021-00782-9
  4. Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
    https://doi.org/10.1017/S1047951120003376
  5. Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
    https://cardiology-conferences.pencis.com/

Yan Shi | Congenital Heart Defects | Best Researcher Award

Dr. Yan Shi | Congenital Heart Defects | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile:

Scopus

Orcid

🌟 DR. YAN SHI: PIONEERING GENETICS RESEARCHER IN CARDIOVASCULAR DEVELOPMENT 🧬❤️

🎓 EARLY ACADEMIC PURSUITS

Yan Shi , a dedicated scientist from China, embarked on her academic journey in the field of life sciences with an undergraduate degree in Biological Engineering from Shenyang University (2008-2012). She continued to follow her passion for genetics at Hunan Normal University, earning a Master’s Degree in Genetics (2012-2014), and later completed her Ph.D. in Genetics in 2019. Throughout her studies, she developed a strong foundation in molecular biology, focusing on the genetic mechanisms underlying human diseases.

🏥 PROFESSIONAL ENDEAVORS

After obtaining her Ph.D., Dr. Yan Shi advanced her career through postdoctoral research at the Department of Pediatric Cardiac Surgery, Guangdong Provincial People's Hospital (2019-2024). In July 2024, she took on a significant role as a Researcher at the South China Key Laboratory of Structural Heart Disease, where she continues to contribute to groundbreaking cardiovascular research.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CONGENITAL HEART DEFECTS

Dr. Yan Shi's primary research focuses on the molecular mechanisms of congenital and familial heart diseases, especially:

  • Tetralogy of Fallot (TOF)

  • Familial Dilated Cardiomyopathy (DCM)

  • Wnt signaling pathways in cardiac development

  • Single coronary artery animal models

She has successfully led and participated in several national-level projects, including:

  • SORBS2's role in familial dilated cardiomyopathy via the AKT pathway (2024-2027).

  • NOTCH1 point mutations leading to Tetralogy of Fallot (2022-2024).

  • Establishing an animal model for single coronary artery using mice (2020-2022).

🏅 IMPACT AND INFLUENCE

Dr. Yan Shi’s work has been widely recognized in the academic community. She has published several influential papers in reputable journals as the first, co-first, or corresponding author, covering:

  • Wnt signaling and cardiomyocyte differentiation

  • NOTCH1 mutations in congenital heart disease

  • Genetic polymorphisms in BVES associated with Tetralogy of Fallot

Additionally, she was a contributor to a team that won the First-Class Guangdong Natural Science Award (2020) for their research on genes regulating cardiovascular development.

📚 ACADEMIC CITES

Her published research has been cited in various genetic, developmental biology, and cardiovascular journals. Some of her notable publications include:

  • "Variants and Molecular Mechanism of NOTCH1 in Congenital Heart Disease" – Corresponding Author

  • "Novel biphasic mechanism of the canonical Wnt signaling component PYGO2 promotes cardiomyocyte differentiation" – First Author

  • "Structure and function of Pygo in organ development" – First Author

🚀 LEGACY AND FUTURE CONTRIBUTIONS

As an emerging leader in the field of genetic cardiology, Dr. Yan Shi’s legacy is shaped by her contributions to understanding the genetic underpinnings of heart disease, which hold promise for improving clinical diagnostics and therapies for congenital heart conditions. Her future work is expected to explore further genetic pathways and their therapeutic targeting, potentially leading to personalized treatments for heart diseases.

📑 NOTABLE PUBLICATIONS

"Novel biphasic mechanism of the canonical Wnt signalling component PYGO2 promotes cardiomyocyte differentiation from hUCMSCs"

Authors: Y Shi, B Qin, X Fan, Y Li, Y Wang, W Yuan, Z Jiang, P Zhu, J Chen, Y Chen, F Li, Y Wan
Journal: Cell and Tissue Research
Year: 2023

"Structure and function of Pygo in organ development dependent and independent Wnt signalling"

Authors: Y Shi, X Wu, S Zhu, H Huang, J Zhuang, H Yuan, W Yuan, P Zhu
Journal: Biochemical Society Transactions
Year: 2020